TARSONS PRODUCTS share price has zoomed 5% and is presently trading at Rs 461.5.
Meanwhile, the BSE HEALTHCARE index is at 44,289.3 (down 0.2%).
Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 1.6%) and Divis Laboratories (up 1.0%).
Biocon (down 2.4%) and KIMS (down 2.2%) are among the top losers today.
Over the last one year, TARSONS PRODUCTS has moved down from Rs 527.8 to Rs 461.5, registering a loss of Rs 66.3 (down 12.6%).
On the other hand, the BSE HEALTHCARE index has moved up from 28,434.4 to 44,289.3, registering a gain of 55.8% during the last 12 months.
The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 172.8%), SUVEN PHARMACEUTICALS (up 124.0%) and Glenmark Pharma (up 100.7%).
Must See: These Segments are Witnessing Incredible Growth with Modi's Push
The BSE Sensex is at 82,984.8 .
The top losers among the BSE Sensex today are Tata Motors (down 2.1%) and MUNDRA PORT & SEZ (down 1.1%). The most traded stocks in the BSE Sensex are Tata Motors and Tata Steel.
In the meantime, NSE Nifty is at 25,412.3 (up 0.1%). Hero Motocorp and Divis Laboratories are among the top gainers in NSE NIFTY.
Over the last 12 months, the BSE Sensex has moved up from 67,467.0 to 82,984.8, registering a gain of 15,517.8 points (up 23.0%).
TARSONS PRODUCTS net profit fell 58.1% YoY to Rs 40 million for the quarter ended June 2024, compared to a profit of Rs 96 million a year ago. Net sales rose 35.5% to Rs 848 million during the period as against Rs 626 million in April-June 2023.
For the year ended March 2023, TARSONS PRODUCTS reported 19.8% decrease in net profit to Rs 807 million compared to net profit of Rs 1,007 million during FY22. Revenue of the company fell 5.8% to Rs 2,832 million during FY23.
The current Price to earnings ratio of TARSONS PRODUCTS, based on rolling 12 month earnings, stands at 66.3.
Equitymaster requests your view! Post a comment on "TARSONS PRODUCTS Gains 5%; BSE HEALTHCARE Index Down 0.2%". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!